Here is What Hedge Funds Think About Cubist Pharmaceuticals Inc (NASDAQ:CBST)

Is Cubist Pharmaceuticals Inc (NASDAQ:CBST) a buy right now? Prominent investors are taking a bearish view. The number of long hedge fund bets stayed the same which is a slightly negative development in our experience

Cubist Pharmaceuticals Inc (NASDAQ:CBST)

According to most traders, hedge funds are perceived as underperforming, outdated investment vehicles of the past. While there are over 8000 funds in operation at present, we hone in on the crème de la crème of this group, close to 450 funds. It is estimated that this group has its hands on most of the smart money’s total asset base, and by monitoring their top stock picks, we have revealed a few investment strategies that have historically outstripped the broader indices. Our small-cap hedge fund strategy beat the S&P 500 index by 18 percentage points annually for a decade in our back tests, and since we’ve started sharing our picks with our subscribers at the end of August 2012, we have beaten the S&P 500 index by 25 percentage points in 6.5 month (see all of our picks from August).

Equally as key, positive insider trading sentiment is a second way to break down the financial markets. As the old adage goes: there are plenty of reasons for a bullish insider to downsize shares of his or her company, but just one, very clear reason why they would buy. Many empirical studies have demonstrated the impressive potential of this method if “monkeys” know where to look (learn more here).

Consequently, let’s take a look at the key action encompassing Cubist Pharmaceuticals Inc (NASDAQ:CBST).

Hedge fund activity in Cubist Pharmaceuticals Inc (NASDAQ:CBST)

At year’s end, a total of 18 of the hedge funds we track were bullish in this stock, a change of 0% from the previous quarter. With hedgies’ capital changing hands, there exists an “upper tier” of noteworthy hedge fund managers who were increasing their stakes substantially.

According to our comprehensive database, Citadel Investment Group, managed by Ken Griffin, holds the most valuable position in Cubist Pharmaceuticals Inc (NASDAQ:CBST). Citadel Investment Group has a $43 million position in the stock, comprising 0.1% of its 13F portfolio. Sitting at the No. 2 spot is William Leland Edwards of Palo Alto Investors, with a $35 million position; 0.5% of its 13F portfolio is allocated to the company. Remaining hedgies with similar optimism include D. E. Shaw’s D E Shaw, Israel Englander’s Millennium Management and Jeffrey Vinik’s Vinik Asset Management.

Judging by the fact that Cubist Pharmaceuticals Inc (NASDAQ:CBST) has experienced declining sentiment from hedge fund managers, it’s safe to say that there was a specific group of hedge funds who sold off their positions entirely in Q4. Intriguingly, Donald Chiboucis’s Columbus Circle Investors sold off the biggest position of all the hedgies we track, comprising about $18 million in stock.. Richard Schimel’s fund, Diamondback Capital, also sold off its stock, about $7 million worth. These transactions are important to note, as aggregate hedge fund interest stayed the same (this is a bearish signal in our experience).

What do corporate executives and insiders think about Cubist Pharmaceuticals Inc (NASDAQ:CBST)?

Bullish insider trading is particularly usable when the primary stock in question has seen transactions within the past 180 days. Over the latest 180-day time period, Cubist Pharmaceuticals Inc (NASDAQ:CBST) has experienced zero unique insiders purchasing, and 9 insider sales (see the details of insider trades here).

With the returns demonstrated by our strategies, everyday investors must always monitor hedge fund and insider trading activity, and Cubist Pharmaceuticals Inc (NASDAQ:CBST) shareholders fit into this picture quite nicely.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Most Expensive Specialty Crops in the World

Movies That Took Ages to Make

The Longest Hollywood Films Ever Made

Most Expensive Concert Stages

The Richest Bands of all Time

10 Most Corrupt Countries 2013 List

10 Countries with the Highest Quality of Life Index

Most Expensive Mattresses in the World

5 Smallest Countries by Land Area

The Ultimate Heartbreak Songs

Richest Teenagers in the World

10 Most Haunted Places in America

10 Best Places to Retire in Florida East Coast

Top 10 Places to See Before You Die

Top 8 Countries in the World Where Justice Prevails

10 Richest States in America

15 Wealthiest Countries in the World

Richest Singers in the World

Most Expensive Tasting Menu in New York City

Most Expensive Baby Items in the World

Most Expensive Hotel Suites in Vegas

Most Expensive Brunch in New York City

Most Expensive Beef Cuts in the World

25 Best Colleges to Get a Job

Top 10 US Supermarkets

The 25 Most Dangerous Cities in the World to Visit

Most Expensive Xbox Games

Top 11 Cities Where Billionaires Live

Top 10 Most Charitable Companies in America

Most Expensive Seafood in the World

The 10 Wildest Conspiracy Theories

The 10 Best Job Markets in the US

Top 10 Accounting Scandals of All Time

The 25 Biggest Cities in the World

Top 10 Best Paying Virtual Jobs

Most Expensive Leather Shoes in the World

Top 6 Things to Buy in March

The 10 Most Stressful Jobs in America – 2014 List

Top 10 Jobs for Introverted People

Top 10 Honeymoon Destinations in the World

Top 10 Highest Paying Jobs in the World

Most Expensive Day-Care in New York City

The 10 Cheapest Places to Retire Abroad

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!